Clinical Trial to Evaluate the Safety, Pharmacokinetic Characteristics of DW5124 and DW5124-R, and the Effect of Food on DW5124 in Healthy Adult Volunteers
Latest Information Update: 13 Jan 2026
At a glance
- Drugs DW 5124 (Primary)
- Indications Dyslipidaemias
- Focus Pharmacokinetics
- Sponsors Daewon Pharmaceutical
Most Recent Events
- 13 Jan 2026 New trial record